Jefferies analyst Omar Nokta reiterates Frontline (NYSE:FRO) with a Buy and maintains $22 price target.
Ecolab Has ‘Earnings Consistency,’ Downside Risk Is ‘Relatively Benign’: Analyst
Shares of Ecolab Inc (NYSE: ECL) were rising in early trading on Wednesday.
The downside risk to the company’s earnings seems “relatively benign,” given its business model and strategy, according to Piper Sandler.
